Simpson Thacher recently represented the international joint lead managers in connection with a follow-on offering of AEON REIT Investment Corporation, which included an international offering to institutional investors pursuant to Rule 144A and Regulation S. The offering raised approximately ¥35.7 billion (US$312 million) for the issuer, which was used with bank financing towards the acquisition of four new properties.

Hill Dickinson has advised on the initial public offering of Greater Manchester-based consumer product group, Ultimate Products. The entire issued share capital of Ultimate Products was admitted to the premium segment of the Official List and to trading on the main market of the London Stock Exchange earlier today.  

King & Wood Mallesons (KWM) has advised G8 Education Limited (G8) on its proposed A$212.8 million placement to CFCG Investment Partners International (Australia) Pty Ltd (CIPI), in its capacity as the Manager of the First Capital Australia Education Master Fund. CIPI is a wholly owned subsidiary of the China First Capital Group Limited.

The KWM team was led by Brisbane Partner Stefan Luke, who was supported by Senior Associate Isaac Evans and Solicitor Akshay Naran.

Hengeler Mueller is advising the underwriters led by Credit Suisse Securities (Europe) Limited (Process Bank), Barclays Bank PLC, Goldman Sachs International, BNP PARIBAS, COMMERZBANK Aktiengesellschaft, HSBC Trinkaus & Burkhardt AG, Morgan Stanley & Co. International plc and UniCredit Bank AG on the announced rights offering of Deutsche Bank AG in the amount of around EUR 8 bn.

Delphi acted as advisor to IRLAB in connection with an IPO of approx. SEK 115 million as well as its listing on Nasdaq First North Premier. The first day of trading was 28 February 2017.

IRLAB is a drug discovery and development company providing novel treatment for disorders of the brain, with focus on Parkinsons disease and dementia. IRLAB has two drug candidates, IRL752 and IRL790, for which clinical phase 1 studies have been completed, three projects in pre-clinical phase as well as a research program that aims at identifying further drug candidates.

Osborne Clarke has advised Shore Capital and Cenkos Securities on the successful £105 million IPO of UP Global Sourcing Holdings plc (Ultimate Products), the innovative consumer goods group, on the premium listing segment of the Official List and main market of the London Stock Exchange. The IPO raised approximately £53 million for the selling shareholders.

Shore Capital is acting as Sponsor, Global Co-ordinator and Bookrunner to Ultimate Products and Cenkos is acting as Joint Bookrunner.

Ashurst has advised Pengxin International Mining Co. Ltd ("Pengxin") on an initial private placement investment of approximately A$81 million in CleanTeq Holdings Limited ("Clean TeQ") in a deal signed 28 February 2017.

Vinge advises Statoil ASA (“Statoil”) in connection with a transaction concerning Lundin Petroleum AB (publ) (“Lundin Petroleum”) and International Petroleum Corporation (“IPC”). The board of Lundin Petroleum has proposed to spin-off certain assets outside of Norway into a newly incorporated company, IPC, and to distribute the shares in IPC as dividend in kind to the shareholders of Lundin Petroleum. The intention is to list the shares of IPC on the Toronto Stock Exchange and Nasdaq Stockholm.

Auris Medical Holding AG, a Swiss clinical-stage company listed at NASDAQ (EARS) and dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, closed a public offering of 10,000,000 common shares and 10,000,000 warrants, each warrant entitling its holder to purchase 0.70 of a common share. The common shares and warrants were sold in units comprised of one common share and one warrant at a public offering price of $1.00 per unit.

Sidley has advised the sole sponsor and the underwriters in the initial public offering of China YuHua Education Corporation Limited (China YuHua Education) on the Stock Exchange of Hong Kong. Our clients were CITIC CLSA Capital Markets Limited as the sole sponsor, as well as CLSA Limited, Merrill Lynch Far East Limited, Merrill Lynch International, CCB International Capital Limited, First Capital Securities Limited and Orient Securities (Hong Kong) Limited as the underwriters. The total offering amount was HK$1.5 billion (approximately US$198 million).